Cmed specializes in complex disease areas, particularly oncology, immuno-oncology, cell therapy and other specialty therapeutics areas. Clinical trials in oncology, especially involving cell & gene therapy (e.g. CAR T cells) are increasingly complex and demanding. Cmed delivers these with expertise, a personalised, flexible approach and a next generation clinical data platform, particularly beneficial for complex trials, including cell therapy studies.